Artificial intelligence driven tumor risk stratification from single-cell transcriptomics using phenotype algebra
eLife · 2025
DOI: 10.7554/elife.98469 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Namrata Bhattacharya und 16 weiteren Autor:innen. Beteiligte Einrichtung: Australian Prostate Cancer Research Centre-Queensland, Faculty of Health, School of Biomedical Sciences, Centre for Genomics and Personalised Health,…. Hauptthemen laut MEDLINE: Single-Cell Analysis, Artificial Intelligence, Transcriptome, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Science and Engineering Research Board.
Abstract (Originalsprache)
Single-cell RNA-sequencing (scRNA-seq) coupled with robust computational analysis facilitates the characterization of phenotypic heterogeneity within tumors. Current scRNA-seq analysis pipelines are capable of identifying a myriad of malignant and non-malignant cell subtypes from single-cell profiling of tumors. However, given the extent of intra-tumoral heterogeneity, it is challenging to assess the risk associated with individual cell subpopulations, primarily due to the complexity of the cancer phenotype space and the lack of clinical annotations associated with tumor scRNA-seq studies. To this end, we introduce SCellBOW, a scRNA-seq analysis framework inspired by document embedding techniques from the domain of Natural Language Processing (NLP). SCellBOW is a novel computational approach that facilitates effective identification and high-quality visualization of single-cell subpopulations. We compared SCellBOW with existing best practice methods for its ability to precisely represent phenotypically divergent cell types across multiple scRNA-seq datasets, including our in-house generated human splenocyte and matched peripheral blood mononuclear cell (PBMC) dataset. For tumor cells, SCellBOW estimates the relative risk associated with each cluster and stratifies them based on their aggressiveness. This is achieved by simulating how the presence or absence of a specific cell subpopulation influences disease prognosis. Using SCellBOW, we identified a hitherto unknown and pervasive AR−/NE low (androgen-receptor-negative, neuroendocrine-low) malignant subpopulation in metastatic prostate cancer with conspicuously high aggressiveness. Overall, the risk-stratification capabilities of SCellBOW hold promise for formulating tailored therapeutic interventions by identifying clinically relevant tumor subpopulations and their impact on prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Australian Prostate Cancer Research Centre-Queensland, Faculty of Health, School of Biomedical Sciences, Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, Australia.
- Department of Computer Science and Engineering, Indraprastha Institute of Information Technology-Delhi (IIIT-Delhi), Okhla, Phase III, New Delhi, India.
- Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Australia.
- Department of Computational Biology, Indraprastha Institute of Information Technology-Delhi (IIIT-Delhi), Okhla, Phase III, New Delhi, India.
- School of Mathematical Sciences, The University of Adelaide, Adelaide, Australia.
- Center for Computational Biomedicine, Harvard Medical School, Boston, United States.
ORCID-Profile: Namrata Bhattacharya, Gaurav Ahuja, Himanshu Kumar, Antoine Roquilly, Jeremie Poschmann, Debarka Sengupta
Förderung
- Department of Biotechnology
- Science and Engineering Research Board
Zitieren
APA
Bhattacharya, N., Rockstroh, A., Deshpande, S. S., Thomas, S. K., Yadav, A., Goswami, C., Chawla, S., Solomon, P., Fourgeux, C., Ahuja, G., Hollier, B., Kumar, H., Roquilly, A., Poschmann, J., Lehman, M., Nelson, C. C., & Sengupta, D. (2025). Artificial intelligence driven tumor risk stratification from single-cell transcriptomics using phenotype algebra. eLife. https://doi.org/10.7554/elife.98469
Vancouver
Bhattacharya N, Rockstroh A, Deshpande SS, Thomas SK, Yadav A, Goswami C, et al. Artificial intelligence driven tumor risk stratification from single-cell transcriptomics using phenotype algebra. eLife. 2025. doi:10.7554/elife.98469
BibTeX
@article{Bhattacharya2025,
author = {Bhattacharya, Namrata and Rockstroh, Anja and Deshpande, Sanket Suhas and Thomas, Sam Koshy and Yadav, Anunay and Goswami, Chitrita and Chawla, Smriti and Solomon, Pierre and Fourgeux, Cynthia and Ahuja, Gaurav and Hollier, Brett and Kumar, Himanshu and Roquilly, Antoine and Poschmann, Jeremie and Lehman, Melanie and Nelson, Colleen C and Sengupta, Debarka},
title = {Artificial intelligence driven tumor risk stratification from single-cell transcriptomics using phenotype algebra},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.98469}
}
EUVIMED